Phosphatidylcholine has emerged as a groundbreaking therapeutic agent in managing inflammatory bowel diseases such as ulcerative colitis and Crohn’s disease. Scientific studies over the past decade, including major publications like Annals of Internal Medicine and Digital Digest, have consistently highlighted its efficacy and safety.